Pfizer hopes FDA will endorse use of COVID-19 vaccine in kids as young as 2 this fall
Pfizer plans to seek approval for its COVID-19 vaccine to be administered to children ages 2 to 11 in September. |!| Kansas City
Pfizer plans to seek approval for its COVID-19 vaccine to be administered to children ages 2 to 11 in September. |!| Kansas City